| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-09-30 | NCT07848880 A Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate… | Phase 2 | Not Yet Recruiting |
| Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2 | 2 | |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07693777 | A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With… | Severe Hypertriglyceridemia (sHTG) | Not Yet Recruiting | 2026-07-10 |
| NCT07680829 | A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia | Severe Hypertriglyceridemia | Not Yet Recruiting | 2026-07-06 |
| Phase 2 | ||||
| NCT07848880 | A Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate… | Hypertriglyceridemia | Not Yet Recruiting | 2026-09-30 |
| NCT07024212 | Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and… | MASLD | Active, Not Recruiting | 2026-07-07 |
| Phase 1/2 | ||||
| NCT07056777 | Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard… | Gastrointestinal Cancer | Recruiting | 2026-06-30 |
| Phase 1 | ||||
| NCT06132828 | Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced… | Solid Tumor | Recruiting | 2026-04-27 |
NASH / MASH (2)